Abiopharma

🔍 OZOLINS MARTY V. (Executive)

Company: Snap-on Inc (SNA)

Report Date: 2026-08-26

Detailed Transactions and Holdings:

• Acquired 800 shares of Common Stock at $168.7 per share (Direct)
  Date: 2026-08-26 | Code: M | equity_swap_involved: 0 | shares_owned_after: 2,325.80 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 800 shares of Common Stock at $400.0 per share (Direct)
  Date: 2026-08-26 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,525.80 | transaction_form_type: 4 | Footnotes: F1
• Sold 800 shares of Stock Option (Right to Buy) at $168.7 per share (Derivative)
  Date: 2026-08-26 | Code: M | Expires: 2027-02-09 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F4, F3
• Holds 1,000 shares of Stock Option (Right to Buy) at $161.18 per share (Derivative)
  Date: 2026-08-26 | Code: H | Expires: 2028-02-15 | shares_owned_after: 1,000.00 | Footnotes: F3
• Holds 1,250 shares of Stock Option (Right to Buy) at $155.92 per share (Derivative)
  Date: 2026-08-26 | Code: H | Expires: 2029-02-14 | shares_owned_after: 1,250.00 | Footnotes: F3
• Holds 1,300 shares of Stock Option (Right to Buy) at $155.34 per share (Derivative)
  Date: 2026-08-26 | Code: H | Expires: 2030-02-13 | shares_owned_after: 1,300.00 | Footnotes: F3
• Holds 1,316 shares of Stock Option (Right to Buy) at $189.89 per share (Derivative)
  Date: 2026-08-26 | Code: H | Expires: 2031-02-11 | shares_owned_after: 1,316.00 | Footnotes: F3
• Holds 1,676 shares of Stock Option (Right to Buy) at $211.67 per share (Derivative)
  Date: 2026-08-26 | Code: H | Expires: 2032-02-10 | shares_owned_after: 1,676.00 | Footnotes: F3
• Holds 1,377 shares of Stock Option (Right to Buy) at $249.26 per share (Derivative)
  Date: 2026-08-26 | Code: H | Expires: 2033-02-09 | shares_owned_after: 1,377.00 | Footnotes: F3
• Holds 1,356 shares of Stock Option (Right to Buy) at $269.0 per share (Derivative)
  Date: 2026-08-26 | Code: H | Expires: 2034-02-15 | Exercise: 2025-02-15 | shares_owned_after: 1,356.00 | Footnotes: F5
• Holds 1,068 shares of Stock Option (Right to Buy) at $339.73 per share (Derivative)
  Date: 2026-08-26 | Code: H | Expires: 2035-02-13 | Exercise: 2026-02-13 | shares_owned_after: 1,068.00 | Footnotes: F5
• Holds 1,084 shares of Stock Option (Right to Buy) at $378.55 per share (Derivative)
  Date: 2026-08-26 | Code: H | Expires: 2036-02-12 | Exercise: 2027-02-12 | shares_owned_after: 1,084.00 | Footnotes: F5
• Holds 292 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-26 | Code: H | Expires: 2027-02-15 | Exercise: 2027-02-15 | shares_owned_after: 292.00 | Footnotes: F6, F7, F7
• Holds 250 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-26 | Code: H | Expires: 2028-02-13 | Exercise: 2028-02-13 | shares_owned_after: 250.00 | Footnotes: F6, F7, F7
• Holds 261 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-26 | Code: H | Expires: 2029-02-12 | Exercise: 2029-02-12 | shares_owned_after: 261.00 | Footnotes: F6, F7, F7
• Holds 585 shares of Performance Units (Derivative)
  Date: 2026-08-26 | Code: H | shares_owned_after: 585.00 | Footnotes: F6, F8, F8
• Holds 499 shares of Performance Units (Derivative)
  Date: 2026-08-26 | Code: H | shares_owned_after: 499.00 | Footnotes: F6, F9, F9
• Holds 522 shares of Performance Units (Derivative)
  Date: 2026-08-26 | Code: H | shares_owned_after: 522.00 | Footnotes: F6, F10, F10
• Holds 3,714 shares of Deferred Stock Units (Derivative)
  Date: 2026-08-26 | Code: H | shares_owned_after: 3,713.96 | Footnotes: F6, F11, F11, F12, F12

Footnotes:

• F1: The option was exercised and the underlying shares were sold pursuant to a Rule 10b5-1 Plan, which was adopted on May 21, 2026.
• F2: Includes 76.6213 shares acquired under the Snap-on Incorporated Employee Stock Ownership Plan and 13.1244 shares acquired under a dividend reinvestment plan.
• F3: Option fully vested.
• F4: Exercise of Rule 16b-3 stock option pursuant to a Rule 10b5-1 Plan, which was adopted on May 21, 2026.
• F5: Original stock option grant vests in three annual installments beginning on the date listed in the "Date Exercisable" column.
• F6: 1 for 1.
• F7: The restricted stock units vest three years from the grant date on the date listed above, assuming continued employment.
• F8: If the Company achieves certain goals over the 2024-2026 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits.
• F9: If the Company achieves certain goals over the 2025-2027 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits.
• F10: If the Company achieves certain goals over the 2026-2028 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits.
• F11: Payment will be made in accordance with the reporting person's deferral election, death, disability or termination of employment.
• F12: This information is based on a plan statement dated June 30, 2026.